Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle K Haas

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Seminars in Respiratory and Critical Care Medicine|March 15, 2016
Mycobacterial Lung Disease Complicating HIV InfectionMichelle K Haas, Charles L Daley
Clinics in Chest Medicine|November 17, 2019
Diagnostic Tests for Latent Tuberculosis InfectionMichelle K Haas, Robert W Belknap
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Updates in the Treatment of Active and Latent TuberculosisMichelle K Haas, Robert W Belknap
Health Policy OPEN|July 27, 2022
The disparate impact of age-based COVID-19 vaccine prioritization by race/ethnicity in Denver, ColoradoKaylynn Aiona, Emily Bacon, Laura J Podewils, et al.
AIDS Research and Human Retroviruses|October 30, 2014
Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivoMichelle K Haas, David N Levy, Joy M Folkvord, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent TuberculosisMichelle K Haas, Kaylynn Aiona, Kristine M Erlandson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2019
Clinical Characteristics of Active Tuberculosis Diagnosed After Starting Treatment for Latent Tuberculosis InfectionAndrew G Flynn, Kaylynn Aiona, Michelle K Haas, et al.
The Pediatric Infectious Disease Journal|August 18, 2020
Interferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health SystemJames Gaensbauer, Janine Young, Cara Harasaki, et al.
Infection Control and Hospital Epidemiology|March 19, 2015
Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardshipNorihiro Yogo, Michelle K Haas, Bryan C Knepper, et al.
Infection Control and Hospital Epidemiology|January 6, 2017
Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare SystemRebecca L Pedela, Katherine C Shihadeh, Bryan C Knepper, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Seminars in Respiratory and Critical Care Medicine|March 15, 2016
Mycobacterial Lung Disease Complicating HIV InfectionMichelle K Haas, Charles L Daley
Clinics in Chest Medicine|November 17, 2019
Diagnostic Tests for Latent Tuberculosis InfectionMichelle K Haas, Robert W Belknap
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Updates in the Treatment of Active and Latent TuberculosisMichelle K Haas, Robert W Belknap
Health Policy OPEN|July 27, 2022
The disparate impact of age-based COVID-19 vaccine prioritization by race/ethnicity in Denver, ColoradoKaylynn Aiona, Emily Bacon, Laura J Podewils, et al.
AIDS Research and Human Retroviruses|October 30, 2014
Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivoMichelle K Haas, David N Levy, Joy M Folkvord, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent TuberculosisMichelle K Haas, Kaylynn Aiona, Kristine M Erlandson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2019
Clinical Characteristics of Active Tuberculosis Diagnosed After Starting Treatment for Latent Tuberculosis InfectionAndrew G Flynn, Kaylynn Aiona, Michelle K Haas, et al.
The Pediatric Infectious Disease Journal|August 18, 2020
Interferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health SystemJames Gaensbauer, Janine Young, Cara Harasaki, et al.
Infection Control and Hospital Epidemiology|March 19, 2015
Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardshipNorihiro Yogo, Michelle K Haas, Bryan C Knepper, et al.
Infection Control and Hospital Epidemiology|January 6, 2017
Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare SystemRebecca L Pedela, Katherine C Shihadeh, Bryan C Knepper, et al.
Pageof 2